Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
Clinical trial NCT07405164 · RECRUITING
Trial details
- NCT number
- NCT07405164
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-23
- Primary completion
- 2034-01-14
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.